Literature DB >> 30260248

Mechanisms of toxic cardiomyopathy.

Philippe Hantson1,2.   

Abstract

BACKGROUND: Dilated cardiomyopathy is a frequent disease responsible for 40-50% of cases of heart failure. Idiopathic cardiomyopathy is a primary disorder often related to familial/genetic predisposition. Before the diagnosis of idiopathic cardiomyopathy is made, clinicians must not only rule out viral and immune causes, but also toxic causes such as drugs, environmental agents, illicit substances and natural toxins.
OBJECTIVE: The objective of this review is to present recent data on the mechanisms underlying toxic cardiomyopathy.
METHODS: The US National Library of Medicine Pubmed database was searched from 1980 to December 2017 utilizing the combinations of the search terms "toxic cardiomyopathy", "drugs", "anticancer drugs", "azidothymidine", "rosiglitazone", "carbon monoxide", "alcohol", "illicit drugs", "cocaine", "metamfetamine", "metals", "venom". A total of 339 articles were screened and papers that dealt with the pathophysiology of toxic cardiomyopathy, either in animal models or in clinical practice were selected, with preference being given to more recently published papers, which left 92 articles. Anticancer drugs: The mechanisms of anthracycline-induced cardiotoxicity are primarily related to their mechanisms of action as anticancer drugs, mainly the inhibition of topoisomerase II β and DNA cleavage. Additional metabolic or oxidative stress factors may play a part, together with interference with iron metabolism. The more recent drugs, trastuzumab and imatinib, also influence stress pathways. Antiretroviral agents: Azidothymidine is cardiotoxic as a result of mitochondrial toxicity. In addition to energy depletion, azidothymidine also increases the production of mitochondrial reactive oxygen species (ROS). Antidiabetic drugs: The cardiotoxicity of thiazolidinedione antidiabetic drugs is still under investigation, though interference with mitochondrial respiration or oxidative stress is suspected. Cocaine: Among the multiple mechanisms involved in cocaine-related cardiotoxicity, excessive sympathetic stimulation with increased myocardial oxygen consumption is well documented in the acute form of left ventricular dysfunction. As for cocaine-related cardiomyopathy, the role of apoptosis and ROS is under investigation. Ethanol: The aetiology of ethanol-related cardiotoxicity is multifactorial, with individual susceptibility being important. It involves apoptosis, alterations of the excitation-contraction coupling in cardiac myocytes, structural and functional alterations of the mitochondria and sarcoplasmic reticulum, changes in cytosolic calcium flows, changes in calcium sensitivity of myofilaments, alterations of mitochondrial oxidation, deregulation of protein synthesis, decrease of contractile proteins and disproportion between the different types of myofibrils, changes in the regulation of myosin ATPase, up-regulation of the L-type calcium channels, increase of oxidative stress, and induction of ANP and p21 mRNA expression in ventricular myocardium. Metamfetamines: Catecholamine-mediated toxicity is the probable cause, with a possible role for genetic susceptibility. Carbon monoxide: In addition to hypoxic injury, carbon monoxide is also directly toxic to the mitochondria, with impairment of mitochondrial respiratory chain at the cytochrome c oxidase level, decrease of glutathione concentrations and of ATP production. There is no evidence for a delayed dilated cardiomyopathy in survivors of an acute exposure. Metals: Cobalt-related cardiomyopathy probably results from interference with energy production and contractile mechanisms, but additional factors (nutrition, hypothyroidism) are often required. Antimony may cause lethal oxidative stress and cell death mediated by elevation in intra-cellular calcium. Proposed mechanisms for mercury toxicity include glutathione depletion, production of ROS, and interruption in selenium-dependent endogenous enzymatic reactions. The existence of a lithium-induced cardiomyopathy is still debated. Scorpion venom: Catecholamine release is the probable cause of acute cardiomyopathy following scorpion envenomation.
CONCLUSIONS: The mechanisms behind toxic cardiomyopathy are complex and multifactorial but include interference with myocardial cell bioenergetics and intracellular calcium handling, the generation of ROS, neurohormonal stress, and induction of apoptosis.

Entities:  

Keywords:  Drugs; environmental agents; illicit substances; metals; natural toxins

Mesh:

Year:  2018        PMID: 30260248     DOI: 10.1080/15563650.2018.1497172

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  18 in total

Review 1.  Genetic Basis of Dilated Cardiomyopathy in Dogs and Its Potential as a Bidirectional Model.

Authors:  Karen R Gaar-Humphreys; Talitha C F Spanjersberg; Giorgia Santarelli; Guy C M Grinwis; Viktor Szatmári; Bernard A J Roelen; Aryan Vink; J Peter van Tintelen; Folkert W Asselbergs; Hille Fieten; Magdalena Harakalova; Frank G van Steenbeek
Journal:  Animals (Basel)       Date:  2022-06-29       Impact factor: 3.231

2.  A Targeted Metabolomics-Based Assay Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Identifies Structural and Functional Cardiotoxicity Potential.

Authors:  Jessica A Palmer; Alan M Smith; Vitalina Gryshkova; Elizabeth L R Donley; Jean-Pierre Valentin; Robert E Burrier
Journal:  Toxicol Sci       Date:  2020-04-01       Impact factor: 4.849

Review 3.  Cocaine and Cardiotoxicity: A Literature Review.

Authors:  Joseph V Pergolizzi; Peter Magnusson; Jo Ann K LeQuang; Frank Breve; Giustino Varrassi
Journal:  Cureus       Date:  2021-04-20

4.  PGE1 triggers Nrf2/HO-1 signal pathway to resist hemin-induced toxicity in mouse cortical neurons.

Authors:  Jiabing Shen; Mao-Sheng Cao; Tingting Zhou; Ying Chen; Jingjing Liang; Yan Song; Chengbin Xue; Mao-Hong Cao; Kaifu Ke
Journal:  Ann Transl Med       Date:  2021-04

5.  Peptide Szeto‑Schiller 31 ameliorates doxorubicin‑induced cardiotoxicity by inhibiting the activation of the p38 MAPK signaling pathway.

Authors:  Li Zhang; Mengwen Feng; Xuejun Wang; Hao Zhang; Jingjing Ding; Zijie Cheng; Lingmei Qian
Journal:  Int J Mol Med       Date:  2021-03-02       Impact factor: 4.101

6.  Cobalt-induced cardiomyopathy - do circulating cobalt levels matter?

Authors:  Mark R J Jenkinson; R M Dominic Meek; Rothwell Tate; Sandy MacMillan; M Helen Grant; Susan Currie
Journal:  Bone Joint Res       Date:  2021-06       Impact factor: 5.853

7.  High-Sensitivity Troponin I and Creatinine Kinase-Myocardial Band in Screening for Myocardial Injury in Patients with Carbon Monoxide Poisoning.

Authors:  June-Sung Kim; Byuk Sung Ko; Chang Hwan Sohn; Youn-Jung Kim; Won Young Kim
Journal:  Diagnostics (Basel)       Date:  2020-04-21

8.  Concurrent Heavy Metal Exposures and Idiopathic Dilated Cardiomyopathy: A Case-Control Study from the Katanga Mining Area of the Democratic Republic of Congo.

Authors:  Didier Malamba-Lez; Désire Tshala-Katumbay; Virginie Bito; Jean-Michel Rigo; Richie Kipenge Kyandabike; Eric Ngoy Yolola; Philippe Katchunga; Béatrice Koba-Bora; Dophra Ngoy-Nkulu
Journal:  Int J Environ Res Public Health       Date:  2021-05-06       Impact factor: 3.390

Review 9.  Sex-Related Differences in Dilated Cardiomyopathy with a Focus on Cardiac Dysfunction in Oncology.

Authors:  Domenico D'Amario; Massimiliano Camilli; Stefano Migliaro; Francesco Canonico; Mattia Galli; Alessandra Arcudi; Rocco Antonio Montone; Josip Andjelo Borovac; Filippo Crea; Gianluigi Savarese
Journal:  Curr Cardiol Rep       Date:  2020-08-08       Impact factor: 2.931

Review 10.  Teaching the basics of the mechanism of doxorubicin-induced cardiotoxicity: Have we been barking up the wrong tree?

Authors:  Balaraman Kalyanaraman
Journal:  Redox Biol       Date:  2019-11-26       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.